Allan Steven Jacobson, Director at PTC THERAPEUTICS, INC. (PTCT), sold 42,040 shares at $56.99 ($2.3M) on 2023-05-11, disclosed to the SEC on 2023-05-12.
Scheduled sale ($2.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.78 | 19,040 | $1.0M | 45.2% |
| 2 | $54.78 | 19,040 | $1.0M | 45.2% |
| 3 | $56.35 | 2,860 | $161K | 7.0% |
| 4 | $56.99 | 1,100 | $63K | 2.7% |
| Total | $54.94 avg | 42,040 | $2.3M | 100% |
| Filing → |
| PTCT | SELL | 2025-09-02 | $167K | — | Filing → |
| PTCT | SELL | 2025-03-06 | $127K | — | Filing → |
| PTCT | SELL | 2024-01-24 | $274K | — | Filing → |